title: Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database.
authors.forename: Anne-Cornélie J M
authors.initials: AC
authors.lastname: de Pont
authors.forename: Roel
authors.initials: R
authors.lastname: Bakx
authors.forename: Marja A
authors.initials: MA
authors.lastname: Boermeester
authors.forename: Marcus J
authors.initials: MJ
authors.lastname: Schultz
mesh_terms: D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D016208:Databases, Factual; D006801:Humans; D011486:Protein C / Q000009:adverse effects* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated